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ABSTRACT
Prescribing errors can cause avoidable harm to patients. 
Most prescriptions originate in primary care, where 
medications tend to be self- administered and errors have 
the most potential to cause harm. Reporting prescribing 
errors can identify trends and reduce the risk of the 
reoccurrence of incidents; however, under- reporting is 
common. The organisation of care and the movement 
of prescriptions from general practice to community 
pharmacy may create difficulties for professionals to 
effectively report errors.
This review aims specifically to identify primary 
research studies that examine barriers and facilitators 
to prescription error reporting across primary care. A 
systematic research of the literature was completed in 
July 2019. Four databases (PubMed/Medline, Cochrane, 
CINAHL and Web of Science) were searched for relevant 
studies. No date or language limits were applied. Eligible 
studies were critically appraised using the Mixed Methods 
Appraisal Tool, and data were descriptively and narratively 
synthesised.
Ten articles were included in the final analysis. Seven 
studies considered prescription errors and error reporting 
within general practice and three within a community 
pharmacy setting. Findings from the included studies 
are presented across five themes, including definition 
of an error, prescribing error reporting culture, reporting 
processes, communication and capacity.
Healthcare professionals appreciate the value of 
prescription error reporting, but there are key barriers 
to implementation, including time, fear of reprisal and 
organisation separation within primary care.
INTRODUCTION
Medication errors can cause unintentional, 
avoidable and potentially severe harm to 
patients,1–4 with an associated economic 
burden to healthcare systems worldwide esti-
mated at $42 billion annually.5 A modelling 
study6 in England revealed that approxi-
mately 237 million medication errors occur 
each year; these were described as being 
able to occur during any aspect of medi-
cation use, from prescribing or dispensing 
to administration and monitoring. While 
administration errors accounted for 54.5% 
of all errors, 92.4% of these were classed as 
having little or no potential for patient harm. 
Prescribing errors constituted 21.3% of all 
errors but accounted for 33.9% of all clin-
ically significant errors, with 71% of these 
occurring in primary care.6
Primary care often provides the first point 
of contact within any healthcare system and 
includes general practice and community 
Key messages
What is already known about this subject?
 ► Of the 80 million prescriptions generated in primary 
care each month in England, around 5% may include 
substandard or unsafe prescribing.
 ► Identifying and learning from errors through re-
porting is only possible where these are effectively 
reported.
 ► Under- reporting of prescribing errors is known to 
exist in primary care settings.
What does this study add?
 ► This study is the first to review literature to exam-
ine the potential facilitators and barriers to reporting 
prescribing errors in primary care.
 ► Healthcare professionals have a poor knowledge of 
what types of prescribing errors need to be reported 
and to whom.
 ► Time, fear of reprisal and poor communication were 
also barriers to reporting prescribing errors.
 ► Community pharmacists could play a bigger role 
in reporting prescribing errors but often lack full 
insight.
 ► Organisation separation between general practices 
and community pharmacies can further create bar-
riers to collaborative working and shared learning 
from errors.
How might this impact on clinical practice or 
future developments?
 ► Further research is needed to discover how pre-
scribing error reporting processes can be optimised 
to support cross- organisational reporting and learn-
ing and improve patient safety.
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pharmacy. Most prescriptions in the UK National Health 
Service (NHS) are generated in primary care, with over 
80 million primary care prescription items processed each 
month in England.7 It has been estimated that around 5% 
of these may include substandard or unsafe prescribing, 
although this figure varies widely.2 4 8 In secondary care 
settings, each of the processes associated with medication 
use mostly takes place within a single organisation such 
as a hospital trust. However, within primary care, these 
stages can cross boundaries of care providers and medi-
cations tend to be self- administered with fewer interac-
tions with healthcare professionals.9 This makes tracking 
and learning from prescribing errors potentially more 
difficult.
A prescribing error has been defined as a prescribing 
decision or writing process that causes ‘an unintentional 
significant reduction in the probability of treatment being 
timely and effective or increase in the risk of harm when 
compared with generally accepted practice’.10 There 
has been some research to date to identify prescribing 
errors within primary care. This has highlighted trends 
including increased prevalence of prescribing errors in 
the elderly,2 11 children2 12 and those with polypharmacy.6 8 
Increased errors have also been found when prescribing 
high- risk medicines12 or in first- time prescriptions.13
Community pharmacists in primary care are in a posi-
tion to identify prescribing errors and intervene before 
dispensing medicines to the patient. However, as general 
practices and community pharmacies are independent 
contractors, shared learning across these organisations 
can be limited. Studies attempting to quantify pharma-
cist prescription interventions have suggested around 
1%–2% of all prescriptions require a pharmacist to 
contact a prescriber for clarifications or corrections.13 
However, community pharmacists have also been found 
to be unlikely to report patient safety incidents, especially 
prescribing errors.14 15
The National Patient Safety Agency was formed in 2001 
to mobilise the patient safety movement within the NHS. 
It recommended that significant event analysis (SEA) 
should be undertaken regularly by primary care teams.16 
This involves an audit of a significant patient safety event 
in order to ascertain what can be learnt from the inci-
dent to improve patient care. It also placed an emphasis 
on reporting patient safety incidents and launched the 
National Reporting and Learning System (NRLS), which 
has improved the frequency and culture of incident 
reporting year on year,16 including a 12.3% increase 
in the number of incidents reported from January to 
March 2020, when compared with the same period in the 
previous year.17 The NRLS enables patient safety incident 
reports to be added to a central database. Reports can then 
be analysed to identify and share patterns and contrib-
utory factors that can help prevent future medication- 
related harm. Reporting can take place in bulk using 
local risk management systems or individually directly to 
the NRLS website using an ‘eForm’.17–20 Currently, only 
larger organisations, mostly within secondary care, have 
purchased a local risk management system, meaning that 
reporting figures from primary care has remained low in 
comparison.20 In 2012, the National Patient Safety Agency 
(NPSA) became part of NHS Improvement, who continue 
to operate the NRLS. Work is currently underway on the 
Development of Patient Safety Incident Management 
System project, which will eventually replace the NRLS. 
This will be designed to work more effectively across 
the whole of the NHS to simplify the reporting of errors 
across all organisations.20
A proactive approach to error reporting has the poten-
tial to identify trends and prevent the reoccurrence 
of incidents that could lead to patient harm,21 22 and 
under- reporting of prescribing errors is known to exist 
in primary care settings.20 23 In addition, the organisation 
of care and the movement of prescriptions from general 
practice to community pharmacy may create difficulties 
for professionals to make decisions about how reporting 
should happen when an error is identified. There is 
a wide body of literature on the identification and 
reporting of medical errors and medicines optimisation 
in primary care. This review aims specifically to identify 
primary research studies that examine barriers and facili-
tators to prescription error reporting across primary care. 
It will consider the influence of sociocultural and contex-
tual influences, feedback systems and learning processes 
as well as key sociotechnical aspects of the use of error 
reporting technologies.
METHODS
A systematic search of the literature was completed by 
NH and KB in July 2019 to identify studies of relevance 
to the research objectives. Databases searched comprised 
PubMed/Medline, Cochrane, CINAHL and Web of 
Science. The search strategy was developed and tested 
in consultation with the review team and was based on 
predefined eligibility criteria as outlined in table 1. No 
date or language limits were applied.
Keywords based on the eligibility criteria were identi-
fied, and a search syntax was created that was adjusted as 
appropriate for each database. A full description of the 
search terms used can be found in online supplemental 
appendix 1. The grey literature was searched using Google 
Scholar and key websites from UK based primary care 
and national healthcare organisations. Reference lists of 
included studies were manually searched for potentially 
relevant papers.
Titles and abstracts were initially screened for rele-
vance independently by KB and NH. Agreement from 
both reviewers was required for full- text review. All 
discrepancies were resolved by discussion. The eligibility 
criteria was applied to potentially relevant full texts inde-
pendently by KB and NH. Papers were excluded if they 
focused primarily on the identification or classification 
of prescribing errors or medicines optimisation interven-
tions. Study selection is summarised using a Preferred 
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Reporting Items for Systematic Reviews and Meta- 
Analyses24 flow diagram (see figure 1)
Each paper was appraised using the Mixed Methods 
Appraisal Tool (MMAT).25 The MMAT provides a set of 
criteria for concomitant appraisal of quantitative, quali-
tative and mixed methods studies. It includes two initial 
screening questions, followed by five quality criteria for 
each study design. Key data, including author, publication 
date, population and setting, study aims and key findings 
were extracted from each study using an electronic data 
extraction form and tabulated to cross- compare learning 
from the included studies.
Due to the nature and heterogeneity of the included 
studies, findings were summarised narratively, using 
guidance provided by the Economic and Social Research 
Council Methods Programme.26 Data specific to 
prescribing was extracted from the findings. Study find-
ings were grouped into themes in order to describe find-
ings across the research and support final conclusions. 
Themes were identified independently and subsequently 
discussed and agreed upon by KB and NH.
Patient and public involvement
It was agreed at the North East Research Design Service 
consumer panel that due to the nature of the research, 
patient and public involvement would not be appro-
priate. Relevant findings will be fed back to an online 
patient and public involvement reference group using 
the VOICE platform.
RESULTS
Searches of the online databases identified 972 records. 
Hand searching of the references listed identified one 
further study. A search of the grey literature identified a 
further two reports. A total of 772 articles were screened 
after removal of duplicates. Screening of title and abstract 
for relevance and suitability removed 758 articles. Full- 
text papers were obtained for the remaining 14 articles 
with four articles reviewed and removed. At full- text 
review, one article was excluded as it was not conducted 
in a primary care setting, and three articles were focused 
on error frequencies or causative factors, without any 
reference to the reporting of errors. A summary of the 
record filtering can be seen figure 1.
Included studies
A total of 10 studies were included in the final analysis; 
a summary of these can be found in table 2. The results 
from the critical appraisal of included studies are found 
in online supplemental appendix 2. Seven studies consid-
ered prescription errors and error reporting within 
general practice27–33 and three within a community phar-
macy setting.34–36 Four studies took place in the USA and 
six studies in the UK, with a total of 206 general prac-
tices and 121 community pharmacies included across all 
studies.
A large amount of variability existed between the 
studies, including: setting, definition and classification 
of a prescribing error, purpose of data collection and 
method of data collection. Findings from the included 
studies are presented across five themes, including defi-
nition of an error, prescribing error reporting culture, 
reporting processes, communication and capacity.
Definition of error
Of the studies that defined a medication or prescrip-
tion error or significant event or incident, definitions 
varied and can be found in table 3. Definitions included 
different levels of specificity and thresholds at which 
something would be constituted as an ‘error’.
Reporting culture
Healthcare professionals seem to see the benefit of 
reporting prescribing errors27 29 32; however, the literature 
suggests a poor knowledge of what types of prescribing 
errors need to be reported and to whom.28 32–34 GP inter-
viewees in one trial32 understood that only serious errors 
would need to be reported to the NRLS. If no or low harm 
to the patient was caused, there was a tendency to discuss 
incidents informally with colleagues.28 32 33 In community 
pharmacy, despite frequent prescription clarification 
and intervention, a prescribing error picked up in the 
Table 1 Literature search eligibility criteria
Criteria Eligibility criteria
Study participants Healthcare professionals and key stakeholders within primary care, including general practitioners 
(GPs), practice nurses, practice administrative staff, community pharmacists and community pharmacy 
technicians and dispensers.
Setting Studies from any primary care setting (general practice, community pharmacy and community health) 
were eligible. No restriction on country was imposed.
Intervention Studies that addressed any aspect of decision making, sociocultural and contextual influences on 
prescription error reporting or key sociotechnical aspects of the use of error reporting technologies.
Outcomes Reporting thresholds, error reporting (beliefs, attitudes and behaviours), use and implementation of 
reporting systems, feedback and learning, health or economic outcomes.
Design No restrictions were based on study design. Research using qualitative, quantitative and/or mixed 
methods approaches were included.
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pharmacy was identified in the study by Kennedy et al35 
as unlikely to be reported if it did not reach the patient.
Various studies highlighted that a supportive and 
open working environment facilitated the reporting and 
discussion of incidents. Fear of reprisal, blame or litiga-
tion were found to act as barriers to honest and open 
reporting.28 29 31 32 A pilot study31 using a novel paper 
error reporting form found that anonymous reporting 
made the reporting process feel less punitive and only 
8% found the process threatening. One study found that 
peer- led reporting, and the opportunity to report more 
informally within a community pharmacy team35 may 
support good reporting practices.
Cresswell et al28 identified that success was dependent on 
key individuals within the practice driving change. Use of 
formal or informal leaders (a ‘champion’) or ‘huddles’ of 
staff within practices who can lead on reporting processes 
was suggested by two of the included studies.28 30
Several studies examined other social- cultural deter-
minants of reporting. This included resistance to change 
and sociocultural variations across primary care organisa-
tions.30 33
Community pharmacists felt reporting prescribing 
errors may create a tension with GPs and potentially 
affect their business.35 Interestingly, GPs also highlighted 
that the commercial nature of general practice may have 
Figure 1 PRISMA24 flow diagram illustrating the study screening process. PRISMA, Preferred Reporting Items for Systematic 
Reviews and Meta- Analyse.
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an influence over reporting error rates, if it damages their 
reputation in a competitive environment.32
Reporting processes
Three studies identified that easy reporting mechanisms 
that fit around daily workload can improve reporting 
rates.28 29 31 However, differences in error reporting across 
primary care can arise due to varying management styles 
and reporting systems, which was addressed in one study 
by individualising interventions.30
One study considered an electronic reporting system: 
Medication Error and Adverse Drug Event Reporting 
System.28 It demonstrated that a web- based reporting 
system is a feasible solution for prescribing error reporting 
in busy primary care environments. The average time 
spent reporting an event was around 4 min, but time pres-
sure was identified as the main barrier to reporting. Inter-
ventions such as incorporating reporting software into a 
patient’s medical record and ongoing reminders to report 
may improve reporting rates.28 29 Reporting contempora-
neously was found in one study to aid memory recall.31
Kennedy et al30 considered error reporting by other 
general practice staff members including nurses and 
administrators and concluded that this can increase 
reporting rates and take some of the pressure from GPs. 
Participants found the intervention acceptable, with 
90.5% agreeing that it would improve patient care and 
90.6% stating the reporting process was not a burden 
to them. However, the authors also found that no one 
continued to report incidents after the study had ended. 
Within community pharmacy, a telephone interview 
with pharmacy technicians highlighted that while 23.6% 
of respondents had identified a prescribing error, only 
2% had completed a report. The study identified that 
upskilling pharmacy technicians would allow the respon-
sibility for error reporting to be shared.34
Communication
Eight studies highlighted the effect communication had 
on prescribing errors and error reporting.27 28 30–32 34–36 
Ineffective written and verbal communication was found 
by study authors to be a frequent contributor to prescribing 
errors,28 32 36 which was compounded by community phar-
macy staff not having access to enough clinical informa-
tion, such as indication or blood test results.36
Face- to- face communication between GPs and phar-
macists was found to improve relationship building and 
collaborative working.27 However, conflicting priorities 
were identified by Phipps et al36 within the community 
pharmacy commercial model, with pharmacists keen to 
protect again substandard prescribing but also relying on 
general practice for their business. The Applied Strate-
gies for Improving Patient Safety Collaborative30 devel-
oped and implemented quality improvement strategies 
within general practices to reduce medication errors. 
Some interventions were based around introducing 
electronic prescribing into general practices, which has 
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conducted in 2005. This study emphasised the benefits 
of using plain English for prescriptions and providing 
additional information to community pharmacists, for 
example, the indication on all prescriptions.
Another study found that a lack of feedback about 
outcomes from reported prescribing errors was a poten-
tial barrier to future reporting.32
Capacity
Half of the studies suggested that clinical workload and 
the associated time constraints had a negative impact 
on the frequency of prescribing errors and reporting of 
errors.27 28 30 32 33 This can be especially problematic for 
part- time or locum workers, where they have less time to 
report and also struggle to effectively integrate into the 
clinical team.27 32 The Pharmacist- led Information Tech-
nology Intervention for Medication Errors or PINCER 
project37 in particular highlighted that pharmacists 
working within general practice who had only a short 
time frame for delivering the intervention (3 days a week 
for up to 12 weeks) struggled to develop meaningful clin-
ical relationships and integrate into the practice team.27
Non- clinical or community pharmacy based staff may 
not fully understand the complexities or nuances of an 
incident and often act as intermediaries without full 
insight into the outcome.29 These groups were also found 
to be missing from SEA discussions.33 GPs may have a 
more in- depth knowledge of the patient and are there-
fore often better informed to report the error27 but can 
have increasing time and workload pressures to balance. 
Therefore, increasing error reporting among non- GP 
staff may increase overall reporting rates.27 29
DISCUSSION
This review is the first to review literature to examine the 
potential facilitators and barriers to reporting prescribing 
errors within primary care. We found that there was no 
standardised definition of a prescribing error or incident 
used in the literature, and this has previously been iden-
tified as a factor for under reporting.2 10 In England, all 
errors should be reported to the NRLS18; guidance from 
the NHS suggests that this should include those errors that 
cause no harm to the patient as well as those that do. For 
example, a prescription error identified by a community 
pharmacist before it was dispensed to a patient should still 
be reported. There is also evidence to suggest that error 
reporting thresholds differ between different healthcare 
professionals and individuals make their own interpreta-
tions about what, when and how to report a prescribing 
error.15 28 38–41 This includes lowering the priority for 
those which resulted in no harm to the patient or near 
miss incidents,41 especially those that could be resolved 
through communication with the prescriber, pharmacist 
and patient.15 This was also identified with hospital phar-
macists, where the severity of the medication error was 
a major factor in deciding to report.42 Other evidence 
suggests individuals and organisations may not use the 
same scale to measure patient harm.12 22 43 Recurrent 
training and feedback is therefore essential to ensure that 
any intervention that aims to improve reporting are using 
a consistent approach.41 42
Workload in general practice is increasing due to 
growing numbers of patients and increasing complexity 
of healthcare needs.44 45 This review identified that these 
increasing demands within primary care can lead to 
conflicting priorities with clinical workflow and a reduc-
tion in prescribing error reporting.27 28 30 32 33 Further-
more, primary care organisations are more likely to use 
varying reporting software that does not link directly to 
the NRLS and currently requires an additional ‘eForm’ 
to be completed.20 The Royal College of General Prac-
titioners described pharmacists as a ‘hidden army’ to 
support general practice45; practice pharmacists as part 
of the multidisciplinary team may help resolve prescrip-
tion queries, reduce prescribing errors46 and increase 
reporting rates.29 Initial work on the PINCER interven-
tion concluded that introducing pharmacists into general 
practice teams was a credible solution to identify and 
reducing prescription errors in general practice.37
Community pharmacists are seen as a safety net for 
prescription errors,15 and this improves patient well- 
being and reduces the risk of harm. Price Waterhouse 
Table 3 Definition of error
Author (year) Definition
De Wet et al (2010)34 Significant event: any event thought by anyone in the primary care team to be significant in the 
care of patients or the conduct of the practice.
Hickner et al (2010)29 Medication error: an error in medication prescribing, dispensing or use that may lead to a 
preventable adverse drug event.
Kennedy et al (2008)30 Prescribing error: any error occurring in the medication use process.
Rea and Griffiths (2016)33 Incident or significant event: an event or incident where GPs have acknowledged a risk to patient 
safety that merits analysis.
Kennedy et al (2006)35 Medication error: any preventable event that may cause or lead to inappropriate medication use 
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Cooper estimated that community pharmacist clarifi-
cation of prescriptions and resolving prescribing errors 
saves the NHS an estimated £468.2 million and contrib-
uted £552.6 million to wider society.47 This financial value 
comes from a range of sources, including reduced GP 
appointments and hospital admissions, reduced medica-
tion waste and reduced risk of litigation.
However, the reporting of prescribing errors is more 
difficult for community pharmacists than practice- based 
staff, with little incentive for pharmacists to report exter-
nally.14 Community pharmacists may not have a sufficient 
knowledge of the patient or the prescribing incident to 
report and worry that reporting will create a tension with 
local prescribers.35 There are also established challenges 
in the transition from traditional dispensing to extended 
clinical roles.48
Communication between community pharmacies and 
general practices can also be problematic. A community 
pharmacist clarifying a prescription will likely contact 
administrative staff who may refer the issue to the GP 
after the telephone conversation and around other clin-
ical workload. This limits peer discussion of the error 
between the GP and the community pharmacist.30 Face- 
to- face and regular interaction between pharmacists and 
GPs has been highlighted as important to develop and 
sustain meaningful clinical relationships27; however, a 
study in this review found that community pharmacy staff 
are rarely included in significant event meetings.33
Having a ‘champion’ to assure the implementation of 
any patient safety intervention and ensure buy- in from 
key stakeholders could improve success rates. The role 
of the medication safety officer (MSO) was introduced 
in 2014 in order to increase medication error reporting 
within an organisation, including NHS Trusts and large 
community pharmacy multiples.49 Clinical commis-
sioning groups, who commission primary care services, 
were invited to nominate an MSO but uptake at the time 
was low.50 At a practice level, individuals, for example, 
practice managers or practice pharmacists, can create 
momentum for change and galvanise the wider team.27 30
Learning from errors and improving the safety of 
healthcare systems is only possible where patient safety 
incidents are effectively reported and promptly analysed 
and disseminated across organisations. However, the 
volume of reports, free- text content and reporting time 
lag poses a challenge,51 52 with systems such as NRLS 
becoming limited in its capacity.11 Using automated tech-
nology for classifying and analysing error reports can 
increase the ability to spot and share trends early and is 
a current focus within the Development of the Patient 
Safety Incident Management System (DPSIMS) project in 
. 11 53 54
This review has some important limitations. While the 
search methodology included ‘incident reporting’ and 
‘error reporting’, some evidence on ‘reporting’ that 
included relevant evidence on prescribing errors may 
have been excluded. We relied on authors’ own defi-
nitions of a prescribing error and did not specifically 
search for papers focused on prescribing medicines for 
higher risk populations, or poor practice prescribing, 
for example. Our search aimed to identify papers where 
prescribing error reporting was a feature. We may have 
missed some papers that contained information on influ-
ences on prescribing error reporting in the text that was 
not highlighted as a key issue or defined as such. Most 
of the studies included did not only examine influences 
on prescribing errors, so data needed to be extracted 
at a broader medication error level. This means that 
some of the conclusions from studies may not have been 
specifically applicable to prescribing errors. However, 
as reporting systems are usually the same for all types of 
errors, most of the findings are likely to be transferable to 
a prescribing error.
There is limited research that is focused on the culture 
of prescribing error reporting within primary care, 
with more emphasis on the prevalence and nature of 
prescribing errors. More research is needed to consider 
the influences of sociocultural and contextual factors on 
prescription error reporting within primary care. Future 
research should also address the technical aspects of error 
reporting technologies, including feedback processes 
that may increase reporting rates.
CONCLUSION
This review has highlighted that although healthcare 
professionals appreciate the value of prescription error 
reporting, there are key barriers to implementation. 
There is not a clear definition of a prescription error nor 
understanding of what to report. Organisation separation 
between general practices and community pharmacies 
can further create barriers to collaborative working and 
shared learning from errors. Further research is needed 
to discover how prescribing error reporting processes can 
be optimised to support learning and improve patient 
safety.
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Appendix 1: Search strategy 
Relevant scientific evidence was identified using online databases (Pubmed, Medline, Cinahl, 
Cochrane, Web of Science).  A search for grey literature was also completed to identify 
studies not included in the databases above and using online tools and websites (e.g. google 
scholar, NHS.uk, gov.uk) as well via direct contact with key contacts/researchers in this area.  
Search terms: (prescriber OR prescribing OR prescription* ) AND ( error* OR mistake* OR 
incident* OR "adverse event*" OR "near miss" OR "near-miss" OR lapse* )) AND ( 
"primary health care" OR "primary care" OR "general practice" OR GP OR "general 
practitioner" OR "family practice" OR "family practitioner" OR "social care" OR 
"community care" OR "community pharmacy" OR "nurse practitioner" ) AND ( report* OR 
learn* OR identif* OR mitigate OR investigat* OR threshold* OR facilitate OR improve) 
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